Definitive Contract 75N93020C00051
Award Date
8/17/20
Potential Completion Date
8/16/21
Potential Value
$3M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Colorado State University
Ultimate Awardee
Colorado State University System
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Fort Collins, CO 80523, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Colorado State University, a public land-grant university, is to develop and manufacture an inactivated virus vaccine using blood pathogen reduction technology to address COVID-19. The award, valued at $19,218,003, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), under a broader NIAID Omnibus Broad Agency Announcement for advanced development of vaccine candidates and therapeutics...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.28 million delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract to Colorado State University Sponsored Programs Division. Colorado State University Sponsored Programs Division will perform Task A07 under the delivery order as the prime contractor. The work will be conducted in Fort...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.6 million delivery order to Colorado State University Sponsored Programs Division, doing business as Sponsored Programs, to establish small animal models for screening monoclonal antibodies and other countermeasures against SARS-CoV-2, the virus that causes COVID-19. This delivery order was issued against the NIAID's Preclinical Models of Infectious Diseases 2017-2024...
This is a federal contract award to Colorado State University, a prominent public land-grant research university, by the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services. The contract, valued at $750,116.00, is a definitive contract with a cost-no-fee pricing type. The contract has no set-aside designation and is for a "CHANGE PO" with a completion date of May 31, 2010. Colorado State University also holds a Basic Ordering...
This is a $1,272,402.60 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Colorado State University for preclinical models of infectious diseases research. The award is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a firm-fixed price structure and an ultimate completion date of August 2, 2025. Colorado State University, a public land-grant research...
This is a $166,383.15 firm-fixed price definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Colorado State University (CSU) on June 1, 2020. The contract is for infectious disease animal research and has a completion date of November 30, 2023. CSU, a public land-grant research university, will perform the work through its Sponsored Programs division. The contract does not have a set-aside designation. CSU has previously provided a range of...
This delivery order from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $14,945.99 to Colorado State University Sponsored Programs Division for work to be conducted from April to August 2021. The task order is issued against the Preclinical Services for HIV Therapeutics indefinite-delivery/indefinite-quantity contract vehicle and requires development and delivery of a quality...
This federal contract award is for an in vitro assessment of antimicrobial activity, with a potential value of $106,534.00. The contract was awarded on September 8, 2017 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Colorado State University's Sponsored Programs division. The contract is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Colorado State University (CSU) for the collection of metadata from in vivo studies performed under previous indefinite-delivery, indefinite-quantity (IDIQ) contract mechanisms. The contract has a ceiling value of $56,795.00 and runs through July 14, 2031. The contract does not have a set-aside designation. CSU's Sponsored Programs division, which has provided a...
This is a delivery order task award under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery, indefinite-quantity (IDIQ) contract. The $2,065,203.31 task order was awarded to Colorado State University (CSU) to provide advanced small animal models for testing candidate preventive interventions against Mycobacterium tuberculosis. The work will be performed in Fort Collins, Colorado. This award is not set aside...